Novartis Reportedly in Talks to Acquire Israeli Stem Cell Developer for up to … – Algemeiner

AlgemeinerGamida-Cell Ltd. Israel stem cell treatment developer Gamida-Cell Ltd. is in talks to be acquired by Novartis, the pharmaceutical giant, for up to $600 million, according to Israel s Globes business daily, citing sources familiar with the deal. Gamida Novartis Trying to Buy Israeli Stem Cell Research DeveloperThe Jewish PressNovartis In Advanced Talks to Acquire Israeli [ ]
http://blog.zandcell.com/novartis-reportedly-in-talks-to-acquire-israeli-stem-cell-developer-for-up-to-algemeiner/?utm_source=rss&utm_medium=rss&utm_campaign=novartis-reportedly-in-talks-to-acquire-israeli-stem-cell-developer-for-up-to-algemeiner